Stocks move mid-day: DE, ABNB, AN, MRNA

Deere’s autonomous 8R tractor


Check out the companies making the biggest moves in the middle of the day:

Deere — Shares rose 7.7% after the company reported earnings per share of $6.55 for the fiscal first quarter, topping the $5.57 expected by analysts polled by Refinitiv. The agricultural machinery manufacturer’s revenue came in at $11.4 billion, against an expected $11.28 billion.

Airbnb — Shares of the vacation rental company fell 5.3%, a day after they rallied 13.35% on a stronger-than-expected fourth-quarter earnings report. Some Wall Street analysts remained cautious on the stock, citing risks including competition and slower-than-expected consumer adoption of alternative accommodations.

Albemarle – The specialty chemicals company sank 10.3%, a day after gaining nearly 5%. Albemarle reported adjusted earnings per share after hours Wednesday, as well as revenue that was in line with expectations, per StreetAccount.

Bio-Rad Laboratories — Shares rose 5.5% after the company reported fourth-quarter net income of $827.7 million, after reporting a loss in the same period a year earlier. The company’s non-operating margin also increased to 17.4% from 15.7% in the same period last year. Nevertheless, earnings and income missed Wall Street estimates.

Zebra Technologies — Shares fell 5.3% after the company forecast sales would fall slightly for the full year. CEO Anders Gustafsson said he is taking a “cautious approach” to the outlook based on an uncertain macro environment. However, Zebra’s fourth-quarter earnings and revenue topped Wall Street estimates.

AutoNation — The auto retailer’s shares rose 9.4% after the company beat fourth-quarter profit and sales expectations. AutoNation reported adjusted earnings of $6.37 per share, versus Refinitiv’s estimate of $5.83. Revenue of $6.7 billion exceeded the expected $6.52 billion.

DraftKings — Shares rose more than 14% after DraftKings reported fourth-quarter results that beat expectations. The sports betting company reported a loss of 53 cents per share on revenue of $855 million. Analysts polled by Refinitiv expected a loss of 59 cents per share on revenue of $800 million.

Moderna — The biotech stock fell more than 4% after its flu vaccine candidate posted mixed results in clinical trials.

Redfin — Shares fell 7.1% even after Redfin reported better-than-expected fourth-quarter results. The real estate company reported a loss of 57 cents per share on $480 million in revenue. Analysts had forecast a loss of $1.08 a share on $445 million in revenue, according to consensus estimates from Refinitiv. Nevertheless, revenues fell from year to year.

Roku — Shares of the streaming device company erased early gains amid a broader selloff on Wall Street. The stock first traded higher after Bank of America doubled down on upgrading the stock to buy from underperform, as the Wall Street firm said Roku is on track for revenue and margin improvement. It was last down 1.2%.

DoorDash — Shares of the food delivery company fell 7.2% after DoorDash reported a mixed fourth quarter. DoorDash reported $1.82 billion in revenue for the quarter, above the $1.77 billion expected according to Refinitiv, and delivered positive guidance. However, the company’s loss of $1.65 per share was more than double what analysts expected.

Biogen — Shares of the biopharmaceutical company rose 1.6% after Japanese drugmaker Eisai said it expects the Food and Drug Administration to fully approve Alzheimer’s treatment Leqembi this summer. Eisai developed the drug with Biogen.

— CNBC’s Jesse Pound Yun Li and Sarah Min contributed reporting.

Leave a Reply

Your email address will not be published. Required fields are marked *